ERBB2 and breast neoplasm: Goreczny et al. reported that increased HIC-5 expression in breast tumors was not related to reduced distant metastasis-free survival when all tumor types were considered, but was correlated with poor outcomes for HER2 + breast tumors.26 In this study, we did not observe a correlation between overall survival and the stromal HIC-5 expression level.